The German specialist medical association SpiFa is the first to use the app to record the effectiveness and safety of vaccinations in a study. docdok.health also sees great potential in Switzerland.
The app that docdok.health brought to market maturity went live in Germany this week. SpiFa recommends its members – 160,000 specialists – and their employees to use the app after their own COVID-19 vaccinations. SpiFa makes the CE-certified app available to its members and medical professionals free of charge.
The collected data can be anonymized and shared with the Paul Ehrlich Institute (PEI).
Great potential in Switzerland too
The aim is to optimize processes and create a broad database for a national investigation of the safety and effectiveness of COVID-19 vaccinations. “We also see great potential for our app in Switzerland,” says Dr. Yves Nordmann, co-founder and Chief Medical Officer of docdok.health.
The expected high number of vaccinations will be an enormous challenge for the medical practitioners involved.
[ source link ]
Safety effectiveness COVID19 vaccinations Swiss startup docdokhealth successful app